Med24
metabolic-therapy 27. 10. 2026 • 2 min read • The American journal of the medical sciences (PubMed)

Metabolic Burden, Metabolic Dysfunction-Associated Steatotic Liver Disease, and Cognitive Performance Among Older Adults: Analysis of 1,387 Participants from the National Health and Nutrition Examination Survey.

BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in older adults, yet its independent contribution to cognitive decline beyond cardiometabolic risk factors remains uncertain. METHODS: We performed a cross-sectional analysis of 1,387 NHANES 2011-2014 participants aged ≥60 years....

Metabolic Burden, Metabolic Dysfunction-Associated Steatotic Liver Disease, and Cognitive Performance Among Older Adults: Analysis of 1,387 Participants from the National Health and Nutrition Examination Survey.

A cross-sectional analysis of 1,387 participants aged 60 years and older from the **NHANES** 2011-2014 investigated the relationship between metabolic dysfunction-associated steatotic liver disease (MASLD), advanced fibrosis likelihood, and cognitive performance.

Sponsored content

Key Clinical Findings

MASLD was defined as a hepatic steatosis index of ≥36 combined with at least one cardiometabolic risk factor, excluding excessive alcohol use. Cognitive performance was assessed using a global z-score composite evaluating memory, verbal fluency, and processing speed. Advanced fibrosis likelihood was determined using validated non-invasive scores. The study adjusted for demographic, lifestyle, and cardiometabolic covariates. Findings revealed that MASLD was not associated with global cognition or individual cognitive domains after full adjustment. Advanced fibrosis risk was unrelated to cognition except for lower **CERAD** memory scores in conjunction with high **FIB-4** scores. A greater metabolic risk factor burden demonstrated graded associations with poorer cognition; specifically, ≥2 risk factors were linked to lower global cognition and memory, and ≥3 risk factors showed borderline memory impairment. Within the MASLD participant group, ≥2 risk factors were associated with lower global cognition, and ≥3 risk factors were associated with reduced verbal fluency. Processing speed declined only at the highest metabolic burden in models stratified by fibrosis severity.

Original Scientific Source
The American journal of the medical sciences (PubMed)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.
metabolic-therapy

Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.

Insulin resistance is an important metabolic derangement contributing to the pathogenesis of type 2 diabetes, obesity, metabolic syndrome, and other chronic diseases, underlining the requirement for techniques that enable in vivo analysis of tissue-specific glucose metabolism. 18F-fluorodeoxyglucose positron emission...

10. 11. 2026 Read article →
Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.
metabolic-therapy

Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.

BACKGROUND: Although body mass index (BMI) is widely used to assess obesity-related health risks, it may fail to detect individuals with normal weight who present with significant cardiometabolic abnormalities. This phenotype, often overlooked in clinical practice, is associated with increased risk of cardiovascular...

30. 10. 2026 Read article →
Advertisement